logo
I Will Never Trust R.F.K. Jr. But I Want to Trust Public Health.

I Will Never Trust R.F.K. Jr. But I Want to Trust Public Health.

New York Times3 days ago

When Health and Human Services Secretary Robert F. Kennedy Jr. fired all 17 members of the Advisory Committee on Immunization Practices on June 9, I was devastated but not surprised. He is a longtime vaccine critic, and it was clear to me that he was gunning for the panel, which gives recommendations to the Centers for Disease Control and Prevention on vaccines.
Though there has been public mistrust of new vaccines, this is not a group that has historically been politicized. In fact, this is the first time that a health and human services secretary has dismissed the full panel. The voting members of the advisory committee are highly vetted experts who typically meet three times a year, and they consider the safety and effectiveness of vaccines, as well as the feasibility of their recommendations. There's a legitimate fear that if the committee stops recommending certain vaccines, they won't be covered by insurance, and Americans will have to pay out of pocket to get them.
On June 10, Kennedy posted on X that he was going to handpick the new panel and that 'none of these individuals will be ideological anti-vaxxers.' He then appointed eight members to the committee, one of whom posted this month, 'The term 'anti-vaxer' it is not a slur, but a compliment. Embrace it. Own it. and be proud to be a part of this fight.' Oy.
As I was processing this information with new horror, I had a possibly perverse response: the urge to listen to a four-hour-and-27-minute 'Huberman Lab' podcast interview with Dr. Jay Bhattacharya, the director of the National Institutes of Health, because the episode was called 'Improving Science & Restoring Trust in Public Health' and was recorded before the advisory committee overhaul.
Bhattacharya, who was a professor of health policy at Stanford University and has an M.D. and a Ph.D., was one of the creators of the Great Barrington Declaration in October 2020, which argued that 'current lockdown policies are producing devastating effects on short- and long-term public health.' His skepticism of mainstream public health during the Biden administration undoubtedly helped Bhattacharya get his current job.
From what I know of Andrew Huberman, he can communicate some scientific concepts quite well, but I am suspicious about his supplement recommendations, his coziness with advertisers and his softball interviews with people like Casey Means. Still, neither Huberman nor Bhattacharya is a vaccine ideologue like Kennedy, and they both have expertise.
Want all of The Times? Subscribe.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mahmoud Khalil arrives in New Jersey after release from ICE custody
Mahmoud Khalil arrives in New Jersey after release from ICE custody

CBS News

time9 minutes ago

  • CBS News

Mahmoud Khalil arrives in New Jersey after release from ICE custody

Mahmoud Khalil has arrived in New Jersey after a federal judge ordered his release from U.S. Immigration and Customs Enforcement detention in Louisiana. The Columbia University graduate and activist arrived on a flight to Newark Liberty International Airport on Saturday after spending months in ICE custody as the Trump administration fights to deport him. He is speaking with reporters at the airport. Watch his remarks in the player above. Khalil released after being detained by ICE for months The Trump administration has been seeking Khalil's deportation for his role in Columbia campus protests against Israel. He has not been charged with any crimes, but the administration says he should leave the country due to activities it deems are aligned with Hamas. "Trump and his administration, they chose the wrong person for this," Khalil said, addressing reporters after leaving the facility on Friday to return to New York. On Friday, U.S. District Judge Michael Fabiarz ruled Khalil is neither a threat to his community nor a flight risk. He called Khalil's detention "highly unusual" and the federal government's actions "an effort to use the immigration charge to punish the petitioner" for his anti-Israel speech. Mahmoud Khalil, an Algerian citizen and U.S. permanent resident, center, speaks after his release from an ICE processing center in Jena, La., Friday, June 20, 2025. Matthew Hinton / AP The government had said in court papers that Secretary of State Marco Rubio determined that Khalil's "presence or activities [in the United States] would compromise a compelling U.S. foreign policy interest." Despite rejecting Rubio's determination to continue to hold Khalil on foreign policy grounds, the judge left open a path for the government to continue its effort to deport him for reasons such as problems with his green card application. Ultimately, the judge determined Khalil does not need to be detained while the deportation proceedings play out. He said he would not order electronic monitoring either. Khalil's arrest set off series of protests Khalil was arrested by federal immigration agents in the lobby of his Columbia-owned Manhattan apartment on March 8, setting off a series of protests and nationwide discussions over free speech. Hours after his arrest, he was transferred to a detention center in Jena, Louisiana, far from his legal team and pregnant wife. The government refused to release him to attend the birth of his son. Khalil's arrest was the first of several similar incidents across the country. Another Columbia activist, Mohsen Mahdawi, who has a green card, was arrested on April 14. Mahdawi was detained for allegedly posing a risk of "adverse foreign policy consequences." He was released about two weeks later by a federal judge who ruled that he was likely being punished for protected speech. He graduated from Columbia after his release. Rumeysa Ozturk, a Tufts University graduate student, was released in May at the order of a federal judge after she was detained for more than a month. Her attorneys said she was taken into custody over to an op-ed she wrote for a campus newspaper. contributed to this report.

Whooping cough outbreaks declared in Iqaluit, Pond Inlet
Whooping cough outbreaks declared in Iqaluit, Pond Inlet

Yahoo

time11 minutes ago

  • Yahoo

Whooping cough outbreaks declared in Iqaluit, Pond Inlet

There's an outbreak of whooping cough in Iqaluit and Pond Inlet, Nunavut, according to the territory's chief public health officer. The Department of Health announced the outbreaks in a pair of news releases Saturday. It said anyone can get the respiratory disease — also known as pertussis — but that the most severe cases are in children under the age of one. Though it spreads easily from person to person, the department says it's preventable by getting vaccinated. Symptoms of whooping cough include a low fever, a cough that lasts longer than a week or is followed by an unusual "whoop" sound, vomiting after coughing and coughing that is worse at night. Anyone with these symptoms is told to stay home, avoid contact with others, and to contact their local health centre. The department says whooping cough can spread from the time someone catches it — before they start coughing — until three weeks after their symptoms have started, or until they've been taking treatment for five days. The department says whooping cough can be treated with antibiotics. They're urging people to get vaccinated against the disease, but also to curb the spread with frequent hand washing, coughing into tissues or sleeves, and not sharing food, drinks, utensils or toothbrushes. Outbreaks of whooping cough that began in Kugaruuk and Naujaat in the spring were declared over last month.

UnitedHealth Group (NYSE:UNH) Announces Debt Financing Totalling US$3 Billion
UnitedHealth Group (NYSE:UNH) Announces Debt Financing Totalling US$3 Billion

Yahoo

time12 minutes ago

  • Yahoo

UnitedHealth Group (NYSE:UNH) Announces Debt Financing Totalling US$3 Billion

UnitedHealth Group recently completed a substantial debt financing deal, raising $3 billion through the issuance of various Notes. This move comes amid a period of legal settlements, such as the $69 million ERISA case, and operational restructuring, including exploring bids for its Latin American operations. Despite these significant developments, the company's stock price remained relatively flat over the last month, reflecting broader market trends which also showed minimal movement. The dividend increase and shareholder discussions on executive compensation may have subtly influenced sentiment, but overall, these events seemed to align with the market's flat performance. UnitedHealth Group has 1 possible red flag we think you should know about. Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit. UnitedHealth Group's recent $3 billion debt financing and restructuring efforts, such as evaluating bids for its Latin American operations, are significant developments. While the near-term stock price remained relatively stable amid these changes, over the past five years, the company's total shareholder return, including dividends, was 13.61%. This reflects a steady growth trajectory, although in the last year, UnitedHealth underperformed the US Healthcare industry. The current share price sees a slight discount from the analyst consensus price target of $547.65, which is 28% higher than the present value. Despite recent legal settlements and compensation discussions, the company's aggressive push towards digital tools and Medicare adjustments might bolster future earnings and revenue. UnitedHealth's projected earnings per share and revenue growth is positioned slightly behind broader market expectations over the next few years, yet planned improvements in operational efficiencies could bridge this gap over time. Learn about UnitedHealth Group's future growth trajectory here. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:UNH. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store